Mitochondrial targeted modification and anticancer mechanism of natural product ergosterol peroxide

Ergosterol peroxide (EP) isolated from the edible medicinal fungus Pleurotus ferulae has a wide range of anti-tumor activity, but poor water solubility and low bioavailability limit further application. In this study, EP was structurally modified using triphenylphosphine (TPP⁺), which combines mitochondrial targeting, amphiphilicity, and cytotoxicity. A series of TPP⁺-conjugated ergosterol peroxide derivatives (TEn) with different length linker arms were synthesized. The structure-activity relationship showed that the Anticancer activity of TEn gradually decreased with the elongation of the linker arm. The compound TE₃ has the optimal and broadest spectrum of antitumor effects. It mainly through targeting mitochondria, inducing ROS production, disrupting mitochondrial function, and activating mitochondria Apoptosis pathway to exert anti-cervical Cancer activity. Among them, TPP⁺ only acted as a mitochondrial targeting group, while EP containing peroxide bridge structure served as an active group to induce ROS. In vivo experiments have shown that TE₃ has better anti-cervical Cancer activity and safety than the first-line Anticancer drug cisplatin, and can activate the immune response in mice. Although TE₃ exhibits some acute toxicity, it is not significant at therapeutic doses. Therefore, TE₃ has the potential for further development as an anti-cervical Cancer drug.

Action mechanism; Anticancer activity; Ergosterol peroxide; Triphenylphosphonium.